Structure

    PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,perMe,Na,0,PA

Occurrence of a D-arabinose-containing complex-type free-N-glycan in the urine of cancer patients

GlyTouCan Accession Number: Loading...

400.0600.0800.010001200m/z0.05.0e+31.0e+4Abundance
Peak Intensity
392.45 45.4

Annotations:

Y PA--??1D-GlcNAc,p@405--4b1D-Man,p/#ycleavage$MONO,perMe,Na,0,PA
393.44 15.1
431.46 25.1

Annotations:

BY ?1D-GlcNAc,p/#bcleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#ycleavage$MONO,perMe,Na,0,PA CZ ?1D-GlcNAc,p/#ccleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#zcleavage$MONO,perMe,Na,0,PA
447.46 15.4
448.47 18.6

Annotations:

CY ?1D-GlcNAc,p/#ccleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#ycleavage$MONO,perMe,Na,0,PA
449.48 126.3

Annotations:

CY ?1D-GlcNAc,p/#ccleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#ycleavage$MONO,perMe,Na,0,PA
450.46 23.5
454.47 22.8

Annotations:

BZ a1D-Man,p/#bcleavage--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA
472.48 29.2

Annotations:

BY a1D-Man,p/#bcleavage--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA CZ a1D-Man,p/#ccleavage--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA
488.52 22.2
542.57 23.2
548.58 12.8
554.62 38.5
572.55 58.4
573.6 14.5
596.63 2289.5

Annotations:

Y PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p/#ycleavage$MONO,perMe,Na,0,PA
597.61 664.1
598.65 92.8
602.58 53.2
603.59 15.3
624.62 236.5
625.62 78.1
626.63 19.0
630.71 12.5
644.57 38.6
646.61 1277.2

Annotations:

B a1D-Man,p/#bcleavage--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,perMe,Na,0,PA
647.61 376.5
648.63 71.1
652.62 15.6
658.62 133.2

Annotations:

BZ b1D-Man,p/#bcleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA
659.64 45.2
664.61 12.2

Annotations:

C a1D-Man,p/#ccleavage--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,perMe,Na,0,PA
676.62 67.1

Annotations:

BY b1D-Man,p/#bcleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA CZ b1D-Man,p/#ccleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA
677.62 23.0
692.67 92.8
693.8 15.1

Annotations:

CY b1D-Man,p/#ccleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA
705.72 25.6
738.67 21.4
752.7 57.5
753.75 21.5
758.75 124.5
759.75 48.5
760.73 20.0
768.72 59.2
769.71 22.3
782.73 17.9

Annotations:

Z PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#zcleavage$MONO,perMe,Na,0,PA
788.68 36.0
789.73 15.0
800.73 13544.0

Annotations:

Y PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p/#ycleavage$MONO,perMe,Na,0,PA
801.64 4982.8
802.68 972.5
806.65 65.1
807.62 29.4
820.63 13.0
822.65 29.6
828.71 37.6
829.65 15.4
830.64 45.2
831.61 17.4
834.66 88.1
835.71 35.9

Annotations:

BY ?1D-GlcNAc,p/#bcleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#ycleavage$MONO,perMe,Na,0,PA CZ ?1D-GlcNAc,p/#ccleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#zcleavage$MONO,perMe,Na,0,PA
836.65 64.9

Annotations:

BY ?1D-GlcNAc,p/#bcleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#ycleavage$MONO,perMe,Na,0,PA CZ ?1D-GlcNAc,p/#ccleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p/#zcleavage$MONO,perMe,Na,0,PA
837.6 22.0
850.68 268.3

Annotations:

B b1D-Man,p/#bcleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,perMe,Na,0,PA
851.66 100.5
852.65 30.9
862.64 294.6

Annotations:

BZ ?1D-GlcNAc,p/#bcleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA
863.65 124.9
864.65 30.5
868.65 27.0

Annotations:

C b1D-Man,p/#ccleavage--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,perMe,Na,0,PA
878.63 19.8
880.68 150.0

Annotations:

BY ?1D-GlcNAc,p/#bcleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA CZ ?1D-GlcNAc,p/#ccleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p$MONO,perMe,Na,0,PA
881.66 59.8
882.66 16.7
924.68 43.9
925.68 21.2
995.78 62.3

Annotations:

ZZ PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p/#zcleavage$MONO,perMe,Na,0,PA
996.74 34.1
997.77 36.0
1013.76 27.6

Annotations:

YZ PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#ycleavage)--4b1D-Gal,p/#zcleavage$MONO,perMe,Na,0,PA ZY PA--??1D-GlcNAc,p@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p/#zcleavage)--4b1D-Gal,p/#ycleavage$MONO,perMe,Na,0,PA
1014.76 17.8
1024.73 45.5
1025.92 16.4
1026.76 129.8
1027.8 60.0
1028.73 15.8
1054.77 574.6

Annotations:

B ?1D-GlcNAc,p/#bcleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,perMe,Na,0,PA
1055.77 284.4
1056.75 83.5
1070.76 176.5
1072.74 2035.9

Annotations:

C ?1D-GlcNAc,p/#ccleavage@405--4b1D-Man,p--3a1D-Man,p--4b1D-GlcNAc,p(--3b1D-Ara,p)--4b1D-Gal,p$MONO,perMe,Na,0,PA
1073.73 1030.1
1074.77 255.4
1098.73 29.7
1114.73 41.9
1115.75 27.7
1116.81 15.2
1157.82 335.8
1158.81 214.2
1159.82 62.2

There are not related spectra

Structure Format

SNFG Oxford Text

Structure details

Reducing Mass: 1398.74
(Calculated Monoisotopic)

Reducing End: 2-Aminopyridine

Persubstitution: Per-methylation

Biological Context

Taxonomy - Homo Sapiens
Tissue - Urine

HPLC

Column

Method

  • 14min gradient with 0.05ml/min run rate
  • 5mM Acetic acid/Triethylamine (pH6.0)
  • 50% acetonitrile

Mass Spec

Thermo Fisher LTQ Linear Ion Trap ESI

Report errors in this entry

UniCarb-DR Creative Commons License

Supported by SIB ExPASy  |  JST / NBDCDICP